ClinicalTrialsFinder
RecruitingNot ApplicableNCT07583823

Elevated Rate Pacing of Cardiac Amyloidosis

Sponsor

University of Minnesota

Enrollment

10 participants

Start Date

Oct 10, 2025

Study Type

INTERVENTIONAL

Conditions

Cardiac AmyloidosisPacemaker

Summary

This study aims to better quantify the improvements in heart failure symptoms and exercise tolerance before and after the heart rate elevation in a cohort of 10 cardiac amyloidosis patients with preexisting pacemakers.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Pacemaker Rate for people with cardiac amyloidosis and pacemaker. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERPacemaker Rate

CA clinic patients with pacemakers will receive a personalized pacing protocol individual to their height and left ventricular ejection fraction.

Locations(1)

University of Minnesota

Minneapolis, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07583823

Related Trials

Prevalence of Cardiac Thrombi in Cardiac Amyloidosis

NCT07648303

[18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis

NCT072324592 locations

Pan-Amyloid PET/CT in Various Amyloid-Related Disease

NCT071305652 locations

Echocardiographic Characterization of Cardiac Amyloidosis

NCT057602871 location

3D Transthoracic Echocardiographic Evaluation on Tricuspid Regurgitation Progression and Clinical Outcomes in Patients With Cardiac Implantable Electronic Device

NCT07793916